Lu L M, Wang J, Yao T
Department of Physiology, Shanghai Medical University, State Key Laboratory for Medical Neurobiology, Shanghai 200032, China.
Sheng Li Xue Bao. 2000 Oct;52(5):371-4.
Experiments were carried out in male Sprague-Dawley rats. The animals were randomly divided into three groups: control, stressed and stress + captopril. Stress stimulations were composed of repeated electric foot-shock combined with noise, twice one day (2 h each session) for 15 consecutive days. Animals in the stress+captopril group were administered with captopril (50 mg/kg.d) intraperitoneally. The results showed that at the end of the 15-day experiment the systolic pressure of the tail artery in stressed rats was significantly higher than that of the control rats, i.e., 19.75+/ C1.0 kPa (n=8, P<0.05) versus 16.32+/ C0.55 kPa (n=7); the vasopressin (AVP) mRNA level in the hypothalamus of the stressed rats also increased significantly compared with that of the control rats, i.e., 12990.33+/ C1533.58 (n=6, P<0.001) versus 7332.66+/ C522.65 (n=6). However, in the stress + captopril rats, both the tail artery systolic pressure and hypothalamic AVP mRNA level were significantly higher than those of the control rats, but lower than those of the stressed rats. In the control rats, no significant change in mean blood pressure (MBP) was observed after intracerebroventricular (icv) injection of 0.3 microgram of d(CH(2))(5)Tyr(Me)AVP, a selective AVP V(1) receptor antagonist; however, a decrease in MBP was observed in both stressed and stress+captopril rats (P<0.05), but the decrease in stress+captopril rats was more obvious than that of the stressed rats after icv a same dose of d(CH(2))(5)Tyr(Me)AVP. These results indicate that the endogenous renin-angiotensin system participates in the mechanism of the stress-induced high blood pressure in rats, and that the effect of Ang II is mediated mainly by stimulating hypothalamic AVP synthesis and release, which in turn result in an increase in blood pressure by acting on the central V (1) receptors.
实验在雄性Sprague-Dawley大鼠身上进行。动物被随机分为三组:对照组、应激组和应激 + 卡托普利组。应激刺激由重复电足击结合噪音组成,每天两次(每次2小时),连续15天。应激 + 卡托普利组的动物腹腔注射卡托普利(50mg/kg·d)。结果显示,在15天实验结束时,应激大鼠尾动脉收缩压显著高于对照组大鼠,即19.75±1.0kPa(n = 8,P < 0.05),而对照组为16.32±0.55kPa(n = 7);应激大鼠下丘脑血管加压素(AVP)mRNA水平也比对照组大鼠显著升高,即12990.33±1533.58(n = 6,P < 0.001),而对照组为7332.66±522.65(n = 6)。然而,应激 + 卡托普利组大鼠的尾动脉收缩压和下丘脑AVP mRNA水平均显著高于对照组大鼠,但低于应激组大鼠。在对照组大鼠中,脑室内(icv)注射0.3微克d(CH(2))(5)Tyr(Me)AVP(一种选择性AVP V(1)受体拮抗剂)后平均血压(MBP)无显著变化;然而,在应激组和应激 + 卡托普利组大鼠中均观察到MBP下降(P < 0.05),但在icv注射相同剂量的d(CH(2))(5)Tyr(Me)AVP后,应激 + 卡托普利组大鼠的血压下降比应激组大鼠更明显。这些结果表明,内源性肾素 - 血管紧张素系统参与大鼠应激性高血压的机制,并且Ang II的作用主要通过刺激下丘脑AVP的合成和释放来介导,进而通过作用于中枢V(1)受体导致血压升高。